Follow-The-Filings

Security · featured owners

TWST Twist Bioscience Corp

Twist Bioscience Corp. Health Care COMMON STOCK Equity as of 2026 Q2 among managers we track

  • 3 Owners
  • Max 3.0%
  • $694M
  • 2 add 1 reduce 1 exit

TWST (Twist Bioscience Corp) is held in 3 featured 13F books as of 2026 Q2. Cathie Wood - Ark Investment Management is the largest tracked holder by portfolio weight (3.0%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 3.0% (Cathie Wood - Ark Investment Management) · not free-float ownership

  1. Cathie Wood Reduce 3.0%
  2. Farallon Capital Management Add 1.0%
  3. Polen Capital Management Add 0.05%

Holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

History
Cathie Wood - Ark Investment Management 2026 Q2 3.0% Reduce −28.3% 4,549,803 $468M History
Farallon Capital Management 2026 Q2 1.0% Add +49.6% 2,136,400 $220M History
Polen Capital Management 2026 Q2 0.05% Add +130.1% 55,310 $6M History
Stanley Druckenmiller - Duquesne Family Office exited 2026 Q2 Last 2026 Q1 0.29% Exit −0.29% 206,000 $10M History

3 current · 1 exited last period · options excluded

SEC filings

Recent issuer filings from EDGAR · 8 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 7.01 Filing Doc
424B7 Filing Doc
8-K 8.01,9.01 Filing Doc
424B5 Filing Doc
8-K 1.01,7.01,9.01 Filing Doc
424B5 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 13 rows shown

Filed Form Detail Links
4 Period Sep 24, 2026 Filing Doc
4 Period Sep 21, 2026 · 3 forms Filing Doc
4 Period Sep 17, 2026 Filing Doc
4 Period Sep 8, 2026 · 4 forms Filing Doc
4 Period Aug 25, 2026 Filing Doc
4 Period Aug 21, 2026 · 6 forms Filing Doc
4 Period Aug 19, 2026 Filing Doc
4 Period Aug 18, 2026 Filing Doc
4 Period Aug 12, 2026 · 2 forms Filing Doc
4 Period Aug 10, 2026 Filing Doc
4 Period Aug 7, 2026 Filing Doc
4 Period Aug 5, 2026 Filing Doc
4 Period Aug 3, 2026 · 2 forms Filing Doc

Updated 4 days ago Source: SEC EDGAR submissions All on EDGAR

Financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $245.11M $312.97M $376.57M
Gross profit * $89.73M $133.35M $191M
Gross margin * 36.6% 42.6% 50.7%
Net income -$204.62M -$208.73M -$77.67M
Net margin * -83.5% -66.7% -20.6%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $424.26M $346.78M $332.97M
Total non-current assets * $352.15M $267.55M $308.9M
Total assets $776.4M $614.32M $641.86M
Total current liabilities $73.32M $71.01M $91.41M
Total non-current liabilities * $79.65M $70.63M $77.5M
Total equity $623.43M $472.69M $472.96M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$142.47M -$64.09M -$47.63M
Cash from investing $50.61M -$3.07M -$24.76M
Cash from financing $0.911M $6.89M $28.54M
Net change in cash -$90.98M -$60.15M -$43.71M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

Ownership over time

filing count by report period · click a bar for that quarter’s holders